From: Immunoexpression of TGF-β/Smad and VEGF-A proteins in serum and BAL fluid of sarcoidosis patients
Stage I | Stages II-III | Acute onset | Insidious onset | |
---|---|---|---|---|
n = 30 | n = 27 | n = 29 | n = 28 | |
Gender | 15 F 15 M | 11 F 16 M | 15 F 14 M | 11 F 17 M |
Age | 38.63 ± 8.84 | 42.88 ± 11.64 | 37.29 ± 12.06 | 36.62 ± 7.12 |
FEV1 [% pred.] | 94.75 ± 14.01 | 92.30 ± 15.33 | 96.81 ± 14.76 | 90.33 ± 13.93 |
FVC [% pred.] | 106.10 ± 12.51 | 102.19 ± 15.32 | 108.62 ± 12.44 | 99.81 ± 14.23 |
FEV1/FVC | 0.75 ± 0.07 | 0.74 ± 0.07 | 0.74 ± 0.07 | 0.74 ± 0.06 |
DLCOc [% pred.] | - | 93.25 ± 16.33 | - | 94.15 ± 17.58 |
BAL-L% | 32.6 ± 16.74 | 28. 88 ± 17.10 | 36.48 ± 16.38 | 24.99 ± 15.90 |
BALF CD4+/CD8+ | 7.60 ± 4.55 | 4.78 ± 4.12 | 8.39 ± 4.56 | 4.42 ± 3.68 |
Ca2+S [mmol/l] | 2.43 ± 0.08 | 2.38 ± 0.23 | 2.39 ± 0.17 | 2.43 ± 0.15 |
Ca2+U [mmol/24 h] | 5.15 ± 2.33 | 4.64 ± 2.96 | 4.27 ± 2.60 | 5.51 ± 2.67 |